Case study: How we helped to ensure integration to the Alzheimer’s Disease pathway

The solution
We conducted 39 web-enabled telephone-depth interviews with Radiologists and Radiology Administrators. The discussion guides for Radiologists and Admins followed a similar flow, with questions tailored to each stakeholder.

• Respondent & facility profiling: Primary practice setting, patient base, decision makers and the capabilities of the image centre and its drivers for expansion
  
  
• Awareness & Impressions: Perceptions of new therapies for AD and feelings about taking on a new care pathway
  
  
• Care pathway walkthrough: Diagnostic process of AD, referrals, technologies in place, how facilities will handle influx of procedures and expansion decision
  
  
• ARIA: Knowledge and experience of  ARIA, comfort in reading scans to analyse support required for staff
  
  
• Wrap up & looking ahead: Motivations to be part of treatment pathway, impact on current capacity of facility, factors that what would trigger fast adoption
  
  

The outputs
Final strategic recommendations were developed by considering all elements of the research. We delivered a structured report helping our client to understand: 

• Current landscape of imaging centre clinical and operational structure in relation to an amyloid beta targeted therapy
  
• Impressions and impact of amyloid beta targeted therapy and potential need for diagnostic AD confirmation
• Impressions and impact of amyloid beta targeted therapy and need for MRI monitoring
  
• Current familiarity and clinical decision making / operational impact of ARIA 
  
• Customer segments among imaging centres and Radiologists